Biorce is a clinical trial technology company offering Aika, an AI-native platform designed to streamline protocol creation, feasibility analyses, and regulatory planning. The platform aims to speed up drug development while maintaining regulatory compliance, building compliant-by-default studies for global submissions. Its solutions are already used across the US, EU, and APAC, and emphasize reducing trial setup time, shortening amendment cycles, and accelerating patient access. The company presents itself as a modern, all-in-one workspace for clinical trial design and regulatory workflows.
No recent deals for this company.